Marcus Maurer
Charite University, Berlin, Germany · Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin · Charite-Universitätsmedizin Berlin
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Marcus Maurer as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:26 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04618211 · Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary AngioedemaPharvaris Netherlands B.V. · completed · Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II · principal investigator
- Ph2NCT03749135 · Dupilumab in Chronic Spontaneous UrticariaCharite University, Berlin, Germany · completed · Chronic Spontaneous Urticaria, Recurrent Angioedema · principal investigator
- Ph2NCT03749148 · Cholinergic Urticaria - Efficacy of DupilumabCharite University, Berlin, Germany · completed · Cholinergic Urticaria · principal investigator
- Ph1NCT02808793 · A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002Allakos Inc. · completed · Indolent Systemic Mastocytosis · principal investigator
- Ph2NCT01984788 · Safety and Efficacy of Oral BCX4161 as a Prophylactic Treatment for HAEBioCryst Pharmaceuticals · completed · Hereditary Angioedema · principal investigator
- N/ANCT01637116 · Profiling Urticaria for the Identification of SubtypesMarcus Maurer · completed · Non-autoreactive Chronic Spontaneous Urticaria, Autoimmune Chronic Spontaneous Urticaria, Autoreactive, Non-autoimmune Chronic Spontaneous Urticaria · principal investigator
- Ph4NCT01586091 · Safety Study of Levocetirizine and FexofenadineCharite University, Berlin, Germany · completed · Pruritus, Chronic Urticaria, Allergic Rhinitis · principal investigator
- Ph2/Ph3NCT01481909 · Study on Mastocytosis for Rupatadine TreatmentMarcus Maurer · completed · Mastocytosis · principal investigator
- Ph4NCT01444196 · Desloratadine 5, 10 and 20mg in Patients With Cold UrticariaMarcus Maurer · completed · Urticaria · principal investigator
- Ph2/Ph3NCT01271075 · Bilastine Updosing - Characterization of Underlying MechanismsCharite University, Berlin, Germany · completed · Cold Contact Urticaria · principal investigator
- Ph2NCT01170936 · Ilaris® in Urticarial Vasculitis - Investigation of Treatment ResponsesCharite University, Berlin, Germany · completed · Urticaria, Vasculitis · principal investigator
- Ph2NCT01045772 · Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS)Charite University, Berlin, Germany · completed · Muckle-Wells Syndrome, Schnitzler Syndrome · principal investigator
- Ph4NCT00600847 · A Study to Assess and Compare the Effects of 5 mg vs. 20 mg Desloratadine on the Development of Cold Urticaria LesionsCharite University, Berlin, Germany · completed · Acquired Cold Urticaria · principal investigator
- Ph3NCT00598611 · Effects of 5 mg vs. 20 mg Desloratadine on Skin Lesions in Patients With Chronic Urticaria (CU)Charite University, Berlin, Germany · completed · Chronic Urticaria · principal investigator
- Ph2NCT00457288 · Efficacy and Safety of TF002 in Cutaneous MastocytosisJADO Technologies GmbH · completed · Cutaneous Mastocytosis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:26 UTC. The ranking covers the 200 most relevant of 260 PubMed records, and a shared surname and initials can bring in a namesake. All 260 on PubMed
- Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.N Engl J Med · 20182,317 citationsRCR 92.6
- 1,521 citationsRCR 81.5
- Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.N Engl J Med · 2013826 citationsRCR 29.1
- Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study.J Clin Oncol · 2005574 citationsRCR 11.8
- Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy.N Engl J Med · 2024482 citationsRCR 76.5
- Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.N Engl J Med · 2010447 citationsRCR 13.8
- Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy.J Allergy Clin Immunol · 2013424 citationsRCR 15.8
- Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy.N Engl J Med · 2025391 citationsRCR 108.0
- The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience.JACC Cardiovasc Interv · 2012381 citationsRCR 13.4
- Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis.Circulation · 2019379 citationsRCR 15.2